Clinical Trials Directory

Trials / Completed

CompletedNCT05473975

Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild · Network
Sex
All
Age
18 Years
Healthy volunteers

Summary

Early recanalization is a major prognostic factor in vascular accidents ischemic brain injury (AIC). The acute phase therapies of AIC aim to recanalization by intravenous thrombolysis and/or mechanical thrombectomy. Recanalization is identified immediately during thrombectomy by per-procedural arteriography. For the thrombolysis, only a performed MRI will validate the recanalization. This "proof of concept" study aims to identify an Electro-Encephalographic biomarker (EEG) of the recanalization in real time, the EEG being easy to set up. This biomarker will be sought during recanalization certified by thrombectomy in order to identify the window time for which the biomarker must be sought on the EEG. During this study, the identified EEG biomarker can be used to validate the recanalization during the intravenous thrombolysis in future studies

Conditions

Interventions

TypeNameDescription
PROCEDUREPlacement of the EGGPlacement of the EGG before the beginning of the thrombectomy

Timeline

Start date
2023-01-24
Primary completion
2025-01-23
Completion
2025-01-23
First posted
2022-07-26
Last updated
2025-06-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05473975. Inclusion in this directory is not an endorsement.